Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-07
DOI
10.1038/s41598-018-36930-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue
- (2018) Anita Calevro et al. PSYCHONEUROENDOCRINOLOGY
- In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact
- (2017) Chantel Kowalchuk et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review
- (2017) Livia J. De Picker et al. Frontiers in Psychiatry
- Microglial activation and progressive brain changes in schizophrenia
- (2016) L E Laskaris et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia
- (2016) Rebecca C. Harvey et al. CNS DRUGS
- Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat
- (2016) Erlyn Limoa et al. Journal of Neuroinflammation
- Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
- (2016) Hadi Khodabandehloo et al. Translational Research
- THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS’ PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS
- (2015) Joseph F. Goldberg et al. DEPRESSION AND ANXIETY
- Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
- (2015) Cenk Tek et al. Early Intervention in Psychiatry
- Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice
- (2015) Gabriele Schoiswohl et al. ENDOCRINOLOGY
- Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses
- (2015) Marie-Caroline Cotel et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of olanzapine on LPS-induced inflammation in rat primary glia cells
- (2015) Caroline Faour-Nmarne et al. Innate Immunity
- Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men
- (2015) Elsa Daurignac et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance andβ-Cell Dysfunction
- (2015) Kevin Noel Keane et al. Oxidative Medicine and Cellular Longevity
- Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro
- (2014) Anitta K. Sárvári et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HTR2Cpolymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: A meta-analysis
- (2014) Xiaojie Ma et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
- (2014) Claire Wu et al. PLoS One
- Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy
- (2013) Elvira Valera et al. GLIA
- Variations in incidence and age of onset of acute and transient psychotic disorders
- (2013) Augusto Castagnini et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Cortical Folding Defects as Markers of Poor Treatment Response in First-Episode Psychosis
- (2013) Lena Palaniyappan et al. JAMA Psychiatry
- Regulation of glucose transport by insulin: traffic control of GLUT4
- (2012) Dara Leto et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia
- (2012) Koichiro Fujimaki et al. PLoS One
- Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice
- (2011) Xiao Yu et al. EMBO JOURNAL
- Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
- (2011) Karina S. MacDowell et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
- (2010) P. J. F. Martins et al. DIABETES
- Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients
- (2010) Kristina I. Melkersson et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
- (2010) Robert J. Fountaine et al. Obesity
- Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
- (2009) Arzu Gunes et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More